Germinoma - 51 Studies Found
Active, not recruiting |
: Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial) :
: 2012-09-28 :
|
Recruiting |
: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors :
|
Completed |
: Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors :
|
Completed |
: Sunitinib in Treating Young Patients With Refractory Solid Tumors :
: |
Terminated |
: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia :
|
Completed |
: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors :
|
Completed |
: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma :
|
Completed |
: Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment :
|
Completed |
: ARQ 197 for Subjects With Relapsed or Refractory Germ Cell Tumors : Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas) : 2010-01-21 : Drug: Tivantinib (ARQ 197) Capsule, 120 mg, BID (360 mg), approximately 112 days |
Completed |
: Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP) : Dysgerminoma : 2005-09-13 : Drug: Darbepoetin alfa |